Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Sensorion named Louis J. Arcudi III chief financial officer effective Oct. 7, 2026. Arcudi was CFO of Amolyt Pharma, acquired by AstraZeneca for up to USD 1.05 billion. Outgoing CFO Laurene Danon will remain as an adviser.
Biotechnology company Sensorion announced the appointment of Louis J. Arcudi III as its Chief Financial Officer, effective October 7, 2026. He succeeds Laurene Danon, who will advise the CEO during the transition. Arcudi brings extensive financial and operational leadership experience from previous roles in the biophar